Why is Vivo Bio Tech falling/rising?

As of 29-Jul, Vivo Bio Tech Ltd. is experiencing a decline in its stock price, currently at Rs 33.05, which reflects a decrease of Rs 1.73 or 4.97%. The stock has been underperforming, having lost 6.9% over the last three days, and it touched an intraday low of Rs 32.23. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The company's recent performance has been disappointing, with a return of -14.13% over the past year, despite a significant profit increase of 187.8%. However, the decrease in promoter holding to 39.06% this quarter raises concerns about investor confidence, contributing to the stock's downward movement.
In the broader market context, Vivo Bio Tech's short-term performance has significantly lagged behind the benchmark, with a 1-week return of -5.89% compared to the Sensex's -1.03%. This underperformance is compounded by a weak long-term fundamental outlook, including a -3.36% CAGR growth in net sales over the last five years and a poor EBIT to interest ratio of 1.99, indicating challenges in servicing its debt. The stock's liquidity is also a concern, with a notable drop in delivery volume, suggesting reduced investor participation. Overall, these factors contribute to a negative sentiment surrounding the stock, reinforcing its current decline.